New Desensitization Strategy: Daratumumab for Highly Sensitized Pediatric Heart Transplant Candidate. Baez Hernandez N, Butts R, Radel L, Bano M, et al. Transplantation 2023;107:e271-e272.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Baez Hernandez N, Butts R, Radel L, Bano M, et al. New Desensitization Strategy: Daratumumab for Highly Sensitized Pediatric Heart Transplant Candidate. Transplantation 2023;107:e271-e272.
PMID: 37749815